Pharming Group N.V. Files 6-K with Press Release
Ticker: PHAR · Form: 6-K · Filed: Feb 20, 2025 · CIK: 1828316
| Field | Detail |
|---|---|
| Company | Pharming Group N.V. (PHAR) |
| Form Type | 6-K |
| Filed Date | Feb 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, press-release
TL;DR
Pharming Group N.V. dropped a 6-K filing on Feb 20, 2025, with a press release attached.
AI Summary
Pharming Group N.V. filed a Form 6-K on February 20, 2025, to furnish a press release dated February 20, 2025. The filing is made under the Securities Exchange Act of 1934 and indicates the company files annual reports under Form 20-F. The press release is provided as Exhibit 99.1.
Why It Matters
This filing provides an update from Pharming Group N.V. to the SEC, likely containing important business or financial information for investors.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) to furnish a press release, not indicating any immediate financial distress or significant new risks.
Key Players & Entities
- Pharming Group N.V. (company) — Registrant
- February 20, 2025 (date) — Filing and Press Release Date
- 001-39822 (other) — SEC File Number
- 20-F (document) — Annual Report Form
- Exhibit 99.1 (document) — Attached Press Release
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is being filed to furnish a press release dated February 20, 2025, as Exhibit 99.1.
What is the SEC file number for Pharming Group N.V.?
The SEC file number for Pharming Group N.V. is 001-39822.
Does Pharming Group N.V. file annual reports under Form 20-F or 40-F?
Pharming Group N.V. files annual reports under cover of Form 20-F.
What is the principal executive office address for Pharming Group N.V.?
The address of the principal executive offices is Darwinweg 24, 2333 CR Leiden, The Netherlands.
What is the SIC code for Pharming Group N.V.?
The Standard Industrial Classification (SIC) code for Pharming Group N.V. is 2834 (Pharmaceutical Preparations).
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on February 20, 2025 regarding Pharming Group N.V. (PHAR).